BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2550648)

  • 1. Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin.
    Wale LJ; Shelton AP; Greenwood D
    J Med Microbiol; 1989 Sep; 30(1):45-9. PubMed ID: 2550648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turbidimetric response of Staphylococcus aureus and Enterococcus faecalis to daptomycin.
    Wale MC; Wale LJ; Greenwood D
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):809-12. PubMed ID: 2850913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Bush LM; Boscia JA; Wendeler M; Pitsakis PG; Kaye D
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1198-200. PubMed ID: 2552901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of an inoculum effect on the estimation of the minimal inhibitory concentration of LY 146032].
    Flandrois JP; Carret G; Pichat C; Peyret M
    Pathol Biol (Paris); 1988 May; 36(5):377-80. PubMed ID: 2841637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
    Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
    Int J Antimicrob Agents; 2004 Jul; 24(1):59-66. PubMed ID: 15225863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin).
    Botha PL; van Heerden CJ; Vorster E; Venter EC
    S Afr Med J; 1988 Jul; 74(1):16-8. PubMed ID: 2838918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
    Hanberger H; Nilsson LE; Maller R; Isaksson B
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1710-6. PubMed ID: 1659305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of daptomycin-metronidazole combinations against mixed bacterial cultures: reduced activity of metronidazole against Bacteroides species in the presence of Enterococcus faecalis.
    Nagy E; Werner H; Heizmann W
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):287-91. PubMed ID: 2161762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids.
    Ledger EVK; Pader V; Edwards AM
    Microbiology (Reading); 2017 Oct; 163(10):1502-1508. PubMed ID: 28942757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of calcium concentration in Muller-Hinton medium on the antimicrobial activity of daptomycin.
    Ito A; Nakaminami H; Wajima T; Noguchi N
    J Glob Antimicrob Resist; 2016 Mar; 4():76-77. PubMed ID: 27436401
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
    Laganas V; Alder J; Silverman JA
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM; Giddey M; Vouillamoz J; Moreillon P
    Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
    DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
    Socha AM; Laplante KL; Russell DJ; Rowley DC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1504-7. PubMed ID: 19185486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.